# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-103276
Filing Date
2026-03-12
Accepted
2026-03-12 10:00:59
Documents
95
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | mcrb-20251231.htm iXBRL | 10-K | 4298640
2 | EX-4.2 | mcrb-ex4_2.htm | EX-4.2 | 27708
3 | EX-10.19 | mcrb-ex10_19.htm | EX-10.19 | 198008
4 | EX-23.1 | mcrb-ex23_1.htm | EX-23.1 | 4235
5 | EX-31.1 | mcrb-ex31_1.htm | EX-31.1 | 13261
6 | EX-31.2 | mcrb-ex31_2.htm | EX-31.2 | 13592
7 | EX-32.1 | mcrb-ex32_1.htm | EX-32.1 | 8938
8 | EX-32.2 | mcrb-ex32_2.htm | EX-32.2 | 8511
| Complete submission text file | 0001193125-26-103276.txt |  | 16512331

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | mcrb-20251231.xsd | EX-101.SCH | 2422305
98 | EXTRACTED XBRL INSTANCE DOCUMENT | mcrb-20251231_htm.xml | XML | 2867671

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37465 | Film No.: 26746057
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)